Singer Jesy Nelson recently shared an emotional update regarding the complications she is experiencing in her pregnancy with twin babies. Former Little Mix singer Jesy, who is having twins with partner Zion Foster, announced that she has been diagnosed with pre-twin-to-twin transfusion syndrome (pre-TTTS). The condition, which is present in pregnancies involving twins with a shared placenta, has serious risks involved and needs intense medical supervision. As Nelson embarks on this difficult journey, her story enlightens us about a rare but dangerous condition many expectant parents may not know much about.
Twin-to-twin transfusion syndrome is a rare but dangerous condition that arises in monochorionic twin pregnancies, in which identical twins share a single placenta. The placenta supplies the developing babies with oxygen, nutrients, and blood flow, but in TTTS, there is an imbalance of blood vessels that interconnect the twins, and thus the vital resources are not evenly distributed. One twin, or the donor twin, shares excess blood with the other, referred to as the recipient twin. This leads to one baby becoming malnourished and possibly anemic, and the other in danger of heart problems due to too much blood.
Nelson described her diagnosis in a heartfelt Instagram video, explaining that she is currently in the pre-stage of TTTS and undergoing frequent monitoring. "I am being scanned twice a week, and each time, things have gotten a little worse," she shared, expressing her fears and hopes for the health of her babies.
If left untreated, TTTS can have devastating consequences. Medical research indicates that:
TTTS usually advances in stages, beginning with minimal changes in fluid levels and worsening as one twin continues to get an unequal share of blood. In extreme cases, fetal laser surgery, referred to as the Solomon technique, can be employed to divide the blood vessels and balance the twins.
Identical twins may develop differently, and their own unique form of placental sharing can have a dramatic effect on pregnancy risk. Jesy Nelson's twins are considered monochorionic diamniotic (mono/di), which means they share a placenta but have two amniotic sacs. This is the type of pregnancy in about 70% of identical twin pregnancies and carries an increased risk of complications like TTTS, umbilical cord entanglement, and growth restriction.
Conversely, dichorionic diamniotic (di/di) twins both have a separate placenta and amniotic sac, which greatly diminishes the threat of TTTS. Twin pregnancy type is normally identified by early ultrasound, with physicians being able to track future complications from inception.
Twin pregnancies, even without the presence of TTTS, entail a variety of health risks to the mother as well as infants:
Over 60% of twin pregnancies end in premature delivery, with birth usually taking place before 37 weeks. Premature infants can have immature organs and need neonatal intensive care (NICU) assistance to assist with breathing, feeding, and infection fighting.
Pregnant women with multiples are at increased risk of having high blood pressure during pregnancy. This, if left untreated, can result in preeclampsia, a serious complication of pregnancy that can result in damage to organs, preterm labor, and in some cases, maternal or fetal death.
Pregnant women carrying multiples are twice as likely to experience anemia, a condition where the body does not produce enough healthy red blood cells. This can lead to fatigue, dizziness, and complications during delivery.
According to John Hopkins Medicine, multiple birth babies are twice as likely to have congenital abnormalities compared to single births. These can include heart defects, neural tube defects, and gastrointestinal issues.
When twins have to share a placenta, they are more likely to have polyhydramnios (excess amniotic fluid) or oligohydramnios (not enough amniotic fluid). Both result in distress to the babies during fetal development and can result in premature labor.
Twins are at increased risk of excessive postpartum hemorrhage because their uterus is larger and there are greater blood supply needs.
Jesy Nelson's openness about her challenging experience is raising awareness for TTTS, a condition that few individuals—let alone expectant mothers and fathers—might be aware of. Through her tearful video, Nelson stressed the significance of knowing about twin pregnancies aside from the thrill of having multiples. "We had no idea that this type of thing occurs when you're having twins. We just desperately want to make people aware of this because there are so many people who aren't aware."
Her case reminds us of the intricacies involved in twin pregnancy and the significance of early identification and medical management. For mothers carrying twins, frequent ultrasounds and vigilance can become a life-and-death issue for early detection and better outcomes of both babies.
Through constant medical attention and care, she and her partner Zion Foster remain positive and get ready for their babies to be born. In other parents whose situations are no different, the story of Nelson highlights awareness, medical progress, and emotional encouragement in handling complicated pregnancies.
The expecting parents of twin siblings are advised to discuss TTTS screening and possible interventions with their physicians to give their babies the best chance.
Credit: iStock
The World Health Organization (WHO) has designated COVID-19 variant PJ.2.1, a descendant of the JN.1 lineage with 24 spike protein changes, as a Variant Under Monitoring (VUM). As of November 8, the variant had been detected in 18 countries, with its share of reported sequences increasing particularly in Canada and the United States.
"Considering the available evidence, the additional public health risk posed by PJ.2.1 is evaluated as low at the global level, with low confidence," the WHO said in its initial risk evaluation published by its Technical Advisory Group on Virus Evolution (TAG-VE).
Laboratory findings suggest that the variant does not show substantial additional antibody escape compared with other circulating variants. Blood samples from recipients of LP.8.1- and XFG-adapted vaccines were also able to neutralize it in laboratory tests.
However, there is insufficient clinical data to determine whether PJ.2.1 causes more severe illness.
Also read: New COVID Variant PJ.2.1 Spreading Globally: Is India At Risk, Are There New Symptoms?
According to the WHO report, "PJ.2.1 is a highly mutated variant with 24 amino acid differences in the Spike protein alone."
First identified in Canada, laboratory studies indicate that it binds more strongly to human ACE2 receptors, which the virus uses to enter cells. However, stronger receptor binding does not necessarily mean faster transmission between people.
The WHO noted that increased receptor binding "may contribute to the observed growth, but do not directly establish increased transmissibility in humans."
The proportion of PJ.2.1 among available global sequences increased from 1% in epidemiological week 33 to 11.6% in week 41, according to the WHO.
As of November 8, 2026, 722 sequences had been submitted to the GISAID, an open access database, from 18 countries.
Read More: New COVID-19 Variant PJ.2.1 Spreads Globally: WHO Says Symptoms Resemble Cold, Flu
In a study involving plasma from 36 recipients of an LP.8.1-adapted vaccine, researchers found no greater antibody evasion against PJ.2.1 than against most tested variants.
Another study involving 22 participants found that neutralisation titres against PJ.2.1 increased 2.8-fold, from 228 before vaccination to 642, at a median of 14 days after an XFG-adapted mRNA vaccine.
These findings suggest that vaccine-induced antibodies can neutralize PJ.2.1 in laboratory tests. However, they do not establish real-world vaccine effectiveness against infection or severe disease, the WHO report said.
"There is currently no evidence establishing greater disease severity associated with PJ.2.1, although comparative clinical data remain limited," the WHO said.
The agency has called for further studies to assess vaccine effectiveness, compare hospitalisations and severe disease outcomes, evaluate antiviral susceptibility and strengthen genomic surveillance.
Dr Gopakumar, Senior Consultant and Head of the Department of Internal Medicine at Apollo Adlux Hospital, Kerala, said the number of mutations alone does not determine how dangerous a variant is.
"The emergence of the new COVID-19 variant PJ.2.1 highlights the virus’s continued ability to evolve. While the reported 24 mutations, particularly in the spike protein, have attracted attention, the number of mutations alone does not determine how dangerous a variant is. What matters clinically is whether these changes make the virus more transmissible, help it evade existing immunity or increase the risk of severe illness," he told HealthandMe.
Dr Navneet Sood, Associate Director and Senior Consultant, Pulmonology, Dharamshila Narayana Superspeciality Hospital, Delhi, added that current evidence does not indicate an increased impact on disease severity compared with previous variants.
"While it is safe to say that the evidence currently shows that there is no increased impact of PJ.2.1 compared to previous variants in disease severity, the WHO's variant surveillance system is still monitoring the potential for new variants to emerge and experts have emphasized the need for genomic monitoring. Public awareness should be centred on identifying respiratory symptoms, testing if required, and taking additional precautions for vulnerable people," he told HealthandMe.
The WHO currently assesses the additional global public health risk from PJ.2.1 as low, although confidence in this assessment remains limited.
There is no need to panic, but experts advise people to remain vigilant. Older adults, immunocompromised individuals and those with chronic illnesses should take particular care. Maintaining respiratory hygiene, ensuring adequate ventilation and seeking medical advice if respiratory symptoms develop remain sensible precautions.
Credit: iStock
Fever, body ache, sore throat or cough? Taking an antibiotic may seem like a quick fix, but it can do more harm than good. Antibiotics treat bacterial infections, not viral illnesses such as colds and flu.
During World Antimicrobial Resistance (AMR) Awareness Week, experts have warned against self-medication, buying antibiotics over the counter and changing prescribed treatment without medical advice. Such practices fuel antimicrobial resistance (AMR), making infections harder to treat.
Dr Jatin Ahuja, Consultant, Infectious Diseases, Indraprastha Apollo Hospital, Delhi, told HealthandMe that resistance is making common bacterial infections increasingly difficult to treat.
"When bacteria develop resistance to multiple classes of antibiotics, fewer effective treatment options remain. This can delay recovery, increase complications and prolong hospital stays. Pneumonia, urinary tract infections and bloodstream infections become particularly challenging when bacteria do not respond to commonly used drugs," he said.
Fever, pain or a sore throat does not automatically mean you need antibiotics.
"Taking antibiotics for viral infections, particularly coughs, colds and flu, does not help recovery," Dr Ahuja said.
Dr Sumit Jain, Director – Internal Medicine, Paras Health, Panchkula, said antibiotics are ineffective against viral infections.
"People will often think that antibiotics are the answer to a fever, body ache, cold, cough or sore throat. They're not. Antibiotics only work against bacterial infections and are of no use at all against viral infections (i.e. the common cold, flu and most of the seasonal respiratory infections)," he told HealthandMe.
Dr Atul Kakar, Chairperson, Internal Medicine, Sir Ganga Ram Hospital, explained that the common cold, flu, most sore throats and many cases of acute bronchitis are caused by viruses.
Viral fevers are generally self-limiting and may resolve within three to seven days with rest, hydration and symptom relief. Antibiotics do not speed up recovery, he told HealthandMe.
Read More: 98 Years After Penicillin: Are We Running Out Of Effective Antibiotics?
Antibiotic resistance develops when bacteria evolve to survive medicines designed to kill them or stop their growth. Inappropriate antibiotic use accelerates this process.
Dr Ahuja warned that resistance to multiple antibiotics leaves doctors with fewer treatment options, increasing the risk of complications and prolonged hospital stays.
Dr Kakar added that resistant bacteria can spread between people at home, in workplaces and in hospitals, making AMR a wider public health threat.
A recent Indian Council of Medical Research (ICMR) study across 20 tertiary-care hospitals found that 61.1% of confirmed infections caused by four major Gram-negative bacteria were carbapenem-resistant.
Published in The Lancet Regional Health – Southeast Asia, the study analysed nearly 1.6 lakh hospitalised patients between April 2022 and April 2025. Patients with resistant infections faced higher mortality, longer hospital stays and substantially higher treatment costs.
The global picture is equally concerning. According to the World Health Organization (WHO), one in six laboratory-confirmed bacterial infections worldwide is already resistant to antibiotics. If current trends persist, drug-resistant infections could contribute to more than 39 million deaths by 2050.
Antibiotics should be taken only when a doctor diagnoses or strongly suspects a bacterial infection.
Dr Ahuja recommended clinical assessment and culture and sensitivity testing, wherever indicated, to identify the bacteria and determine which medicines are likely to work.
Vaccination, hand hygiene and infection-control measures can also help prevent infections and reduce antibiotic use.
Self-medicating, using leftover antibiotics or taking them without a prescription can accelerate resistance and make future bacterial infections harder to treat.
Dr Jain also warned of side effects, including diarrhoea, allergic reactions and disruption of normal gut flora.
He advised against self-medication and recommended consulting a doctor if symptoms persist or worsen.
Antibiotics are not a quick fix for every fever, cough or body ache. Use them only when medically necessary to help keep these medicines effective.
Credit: iStock
The US has lost its measles elimination status after maintaining it for about 26 years. Doctors now warn that declining vaccination rates could trigger a resurgence of other vaccine-preventable diseases, including mumps, rubella and whooping cough.
Measles is highly contagious but preventable with two doses of the measles, mumps and rubella (MMR) vaccine. However, declining vaccination coverage and anti-vaccine rhetoric from US President Donald Trump and Health Secretary Robert F. Kennedy Jr. have raised concerns about the country's ability to contain outbreaks.
Experts fear measles could be the first of several preventable diseases to return.
"This resurgence is an early warning signal demonstrating that vaccination, surveillance, and public trust have all eroded and other preventable diseases are likely to follow," said Rochelle Walensky, who led the Centers for Disease Control and Prevention (CDC) from 2021 to 2023.
Tom Frieden, who headed the CDC from 2009 to 2017, called measles "like a canary in the coal mine for other vaccine-preventable illnesses", warning that it may not be the last disease to resurface, CIDRAP News reported.
The US outbreak has caused more than 5,000 cases and 11 deaths. Declining vaccination coverage and imported cases linked to international travel have added to the spread.
Falling MMR vaccination coverage could also leave Americans vulnerable to mumps and rubella.
Cases of both infections could rise over the next several years, predicted William Schaffner, an infectious disease physician at Vanderbilt Medical Center and spokesperson for the Infectious Diseases Society of America.
He expects mumps to emerge first, given its higher global prevalence. Earlier this year, San Diego State University reported an outbreak among its football team.
Professor Peter Hotez of Texas Children's Hospital warned that measles was just "the first domino to fall".
"I also expect congenital rubella birth defects to return, as well as pertussis next year," he said.
Experts are particularly concerned about pertussis, or whooping cough, as coverage of the diphtheria, tetanus and pertussis (DTaP) vaccine has also declined.
"Whooping cough has a vivid name, and it deserves it," Schaffner said. The bacterial infection inflames the airways, causing breathing difficulties and intense coughing bouts that can produce a distinctive "whoop" sound.
Schaffner recalled diagnosing a young adult based on the sound of their cough alone during his early years as a physician.
Hotez warned that measles could also become a recurring seasonal threat. "Now that measles has returned, we should expect annual late winter to early spring surges just like we did in the pre-vaccine era, and as we've now seen in 2025-2026," he said.
Read More: What Happens After Measles Infection? The Hidden Risks That Can Last For Years
Schaffner is also watching for a possible rise in tetanus cases because the vaccine protecting against whooping cough is administered alongside tetanus and diphtheria protection.
He also flagged chickenpox, which spreads rapidly among unvaccinated children.
In 2022, an unvaccinated 20-year-old man in Rockland County, New York, contracted polio and developed paralysis.
"It's very distressing, because there is a strong element of turning back the clock, or the calendar, to the bad old days," Schaffner said.
He blamed messaging from Washington that has undermined confidence in vaccines and contributed to growing scepticism.
Hotez suggested considering a three-dose MMR schedule starting at six months, instead of the current recommended starting age of 12 months. He also said some adults born before 1989 may need a second dose.
To regain measles elimination status, the US must interrupt transmission for at least 12 consecutive months before submitting a plan to the World Health Organization (WHO).
Restoring vaccination coverage, strengthening disease surveillance and rebuilding public trust will be essential to preventing further outbreaks.
© $2026 Times Horizon Private Limited